Overview

Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg

Status:
Completed
Trial end date:
2021-06-15
Target enrollment:
Participant gender:
Summary
A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-398
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical